Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Traditionally hep C transmits sexually mostly among HIV-positive men who have sex with men.
Researchers believe that hepatitis C is spreading through sex from the HIV-positive population to those who don’t have HIV.
A study finds that CD4 cells decline after people with HIV contract hepatitis C.
HIV-positive men who have sex with men in Western nations historically have a significant risk of contracting hepatitis C through sex.
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
This finding stresses the need to reduce the risk of sexual transmission of hep C among HIV-positive men who have sex with men.
This finding follows a recent study indicating that syphilis is on the rise among heterosexual people who inject drugs.
Researchers found that free testosterone levels were low even after successful treatment for hep C.
Hepatitis C increases risk of death among people on HIV treatment.
This is according to the large randomized controlled START trial.
Indicators of liver health improved at the same rate among those with cirrhosis who were cured of hep C regardless of their HIV status.
Better antiretrovirals have likely mitigated HIV’s effects on the risk of end-stage liver disease and liver cancer in those with hep C.
Researchers analyzed 10 biomarkers associated with biological aging among a group of HIV-positive and -negative Europeans.
Protease inhibitors, including those used for hep C, and various other drugs may cause drug-drug interactions with statins.
In an analysis of the liver health of a cohort of HIV/hep B–coinfected people, one third had significant fibrosis.
Those with greater fibrosis before treating hep C see the greatest benefit.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.